Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Arcus Biosciences (NYSE:RCUS) said on Thursday that its experimental drug candidate, quemliclustat, has received orphan drug status from the U.S. FDA. Quemliclustat is a type of medication that works ...

About Arcus Biosciences Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer.

Gilead Sciences has forged closer ties to its cancer drug partner Arcus Biosciences , although a licensing deal doesn't go as far as the takeover that some market commentators have been predicting ...

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...

The future of fluidics in healthcare: Blake Webb shares trends in automation and microfluidics that are reshaping medical diagnostics and laboratory processes.

A senior Cuban diplomat has accused the Trump administration of trying to discredit the thousands of Cuban doctors working around the world and deprive the country of an important source of income.

Logos Space Services has raised $50 million to advance engineering plans for more than 4,000 broadband satellites, the startup founded by a former Google executive and NASA project manager ...

A new PA11-SMI polymer blend kills bacteria and is SLS-printable, enabling the creation of antimicrobial medical devices like tubing, gowns, and implants.

The decal debate continues. During Wednesday night’s “NBA Countdown” on ABC, NBA commissioner Adam Silver responded to criticism of the digitally inserted images of the Larry O’Brien ...